Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Oncogenex Pharmaceuticals Inc.

Headquarters: Bothell, WA, United States of America
Website: N/A
Year Founded: 1991
Status: Merged

BioCentury | Nov 10, 2016
Clinical News

Apatorsen: Final Ph II data

BioCentury | Oct 24, 2016
Clinical News

Custirsen sodium: Phase III final data

BioCentury | Sep 5, 2016
Clinical News

Custirsen sodium: Phase III data

BioCentury | Apr 4, 2016
Finance

Restructuring watch

BioCentury | Feb 15, 2016
Company News

OncoGenex cancer news

BioCentury | Jan 25, 2016
Clinical News

Apatorsen: Phase II data

BioCentury | Dec 21, 2015
Clinical News

Apatorsen: Phase II ongoing

BioCentury | Dec 7, 2015
Analyst Picks & Changes

Analyst picks & changes

BioCentury | Oct 19, 2015
Clinical News

Apatorsen: Completed Phase II enrollment

BioCentury | Sep 28, 2015
Clinical News

Apatorsen: Phase II data

Items per page:
1 - 10 of 109